关注
gerald raverot
gerald raverot
Hospices Civils de Lyon, Lyon university
在 chu-lyon.fr 的电子邮件经过验证
标题
引用次数
年份
Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement
T Cuny, R Reynaud, G Raverot, R Coutant, P Chanson, D Kariyawasam, ...
Annales d'Endocrinologie, 2024
2024
Letter to the editor from Salle et al.:“A prospective multicenter observational study of surgical versus non-surgical management for pituitary apoplexy”
L Salle, G Raverot, H Salle
The Journal of Clinical Endocrinology & Metabolism 109 (7), e1555-e1556, 2024
12024
Corrigendum to" Pneumocystis pneumoniae in patients with Cushing's syndrome: A French multicentric retrospective study. Annales d'Endocinologie 84 (2022) 37-44]"
A Lugat, H Lasolle, M François, N Benhenda, L Bricaire, E Cornu, ...
Annales d'endocrinologie, S0003-4266 (24) 00056-8, 2024
2024
Evidence for somatic mutation screening on aggressive prolactinomas
M Theodoropoulou, S Petersenn, P Chanson, G Raverot
Nature Reviews Endocrinology, 1-2, 2024
2024
Gonadotropic status in adult women with pituitary stalk interruption syndrome
A Terray, B Baussart, M Zins, M Goldberg, S Kab, L Cazabat, M Briere, ...
European Journal of Endocrinology, lvae064, 2024
2024
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
MR Gadelha, A Casagrande, CJ Strasburger, M Bidlingmaier, PJ Snyder, ...
The Journal of Clinical Endocrinology & Metabolism, dgae385, 2024
12024
Long-term safety and efficacy of subcutaneous pasireotide in patients with cushing
F Bogazzi, S Cannavo, C Giordano, M Detomas, C Scaroni, G Raverot, ...
Endocrine Abstracts 99, 2024
2024
Deciphering microenvironment interactions during age-related pituitary tumour onset and through orthotopic mouse pre-clinical model
A Flores-Martinez, M Chanal, M Daura, A Vasiljevic, R Bolbos, ...
Endocrine Abstracts 99, 2024
2024
Mast cells, a new actor in gonadotroph tumors
MD Ilie, M Lepetit, M Chanal, A Vasiljevic, E Jouanneau, O Gandrillon, ...
Endocrine Abstracts 99, 2024
2024
B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter study
AD De, G Gkasdaris, C Briet, F Almairac, J Boetto, C Mouly, ...
Endocrine Abstracts 99, 2024
2024
Gonadotroph pituitary tumors: not always nonfunctioning
A Carretti, IM Diana, A Vasiljevic, ML Jaffrain-Rea, E Jouanneau, ...
Endocrine Abstracts 99, 2024
2024
Results of systematic KDM1A genotyping in a large series of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) patients and analysis of the genotype/phenotype correlation
L Bouys, A Vaczlavik, P Vaduva, A Jouinot, F Violon, A Berthon, ...
Endocrine Abstracts 99, 2024
2024
Constitutional duplication of PRKACA gene is a cause of isolated primary pigmented nodular adrenocortical disease (PPNAD)
P Vaduva, F Violon, G Raverot, E Stephanie, A Attia, L Bouys, ...
Endocrine Abstracts 99, 2024
2024
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial
B Gatta-Cherifi, K Mohammedi, T Cariou, C Poitou, P Touraine, G Raverot, ...
European Journal of Endocrinology 190 (4), 257-265, 2024
32024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis
KKY Ho, M Fleseriu, J Wass, L Katznelson, G Raverot, AS Little, ...
The Lancet Diabetes & Endocrinology 12 (3), 209-214, 2024
42024
Hypogonadotropic hypogonadism: Never forget iron
E Dybal, G Raverot, AB de la Perrière
Annales d'endocrinologie 85 (1), 92-93, 2024
2024
Carney complex predisposes to breast cancer: prospective study of 50 women
P Vaduva, F Violon, A Jouinot, L Bouys, S Espiard, F Bonnet-Serrano, ...
European Journal of Endocrinology 190 (2), 121-129, 2024
2024
Pituitary apoplexy score, toward standardized decision-making: a descriptive study
H Salle, M Cane, M Rocher, E Auditeau, MP Teissier, G Raverot, L Salle
Pituitary 27 (1), 77-87, 2024
42024
Minerva Endocrinology 2024 Jan 19
D DE ALCUBIERRE, AL CARRETTI, F DUCRAY, E JOUANNEAU, ...
Minerva 19, 2024
2024
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide.
AL Carretti, F Ducray, E Jouanneau, G Raverot, MD Ilie
Minerva Endocrinology, 2024
22024
系统目前无法执行此操作,请稍后再试。
文章 1–20